Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2020-12-14 Director's Dealing
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo giao dịch cổ phiếu của người có liên quan đến người nội bộ Trần Thị Hồng
Director's Dealing Classification · 98% confidence The document is a notice of transaction in shares/fund certificates by an insider (internal person of the public company) and a related person, detailing their personal share trade (number of shares before, number to trade, after, purpose, method, period). This matches the definition of Director’s Dealing (insider trades) rather than a company repurchase or other category.
2020-12-14 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của người có liên quan đến Người nội bộ Trần Thị Hồng
Director's Dealing Classification · 93% confidence The document is a formal report filed by an insider and a related person detailing share transactions (number of shares before, registered to trade, actual traded, method, period, reasons) involving company directors/executives. This aligns exactly with the “Director’s Dealing” category for insider trades rather than a corporate buyback or a general announcement. Therefore, the correct classification is DIRS.
2020-12-03 Vietnamese
IMP: Báo cáo về thay đổi sở hữu của cổ đông lớn KWE Beteilgungen AG
Major Shareholding Notification Classification · 95% confidence The document is a formal report to the State Securities Commission and stock exchange detailing changes in ownership proportions by an institutional investor (KWE BETEILIGUNGEN AG) exceeding the 5% threshold. It lists share counts before and after the transaction, the date of change, and reasons for change in ownership. This aligns with a Major Shareholding Notification (MRQ) which covers notifications of changes in significant share ownership levels.
2020-11-13 Tagalog
IMP: Thông báo về việc niêm yết và giao dịch cổ phiếu thay đổi niêm yết
Share Issue/Capital Change Classification · 91% confidence The document is a one-page regulatory notice from the Ho Chi Minh Stock Exchange announcing changes in the listing due to a new share issuance under the employee stock option program, including updated share counts, effective dates, and trading schedule. This clearly matches an announcement of capital change or share issue. It is not an annual or interim report but a transaction notification of share issuance, so it falls under Share Issue/Capital Change (SHA).
2020-11-02 Vietnamese
IMP: Quyết định thay đổi niêm yết
Share Issue/Capital Change Classification · 92% confidence The document is a formal decision issued by the Ho Chi Minh Stock Exchange approving a change in the registered listing of Imexpharm shares, including details of share counts before and after issuance and the effective date. This represents a capital change/increase in share issuance rather than a general report or management notice. It fits the "Share Issue/Capital Change" category.
2020-10-30 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của người có liên quan đến người nội bộ Trần Thị Hồng
Director's Dealing Classification · 95% confidence The document is a Vietnamese Appendix 10 “Notice of transaction in shares/fund certificates of internal person of public company,” detailing insider share transactions by related parties, including positions, share counts before and after trade, dates, and purposes. This is precisely an insider trading disclosure by directors/executives, matching the ‘Director’s Dealing’ category.
2020-10-30 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.